CN101391065B - 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 - Google Patents
一种用于治疗急慢性盆腔炎的木鳖子花椒汤 Download PDFInfo
- Publication number
- CN101391065B CN101391065B CN2008101584438A CN200810158443A CN101391065B CN 101391065 B CN101391065 B CN 101391065B CN 2008101584438 A CN2008101584438 A CN 2008101584438A CN 200810158443 A CN200810158443 A CN 200810158443A CN 101391065 B CN101391065 B CN 101391065B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pelvic inflammatory
- soup
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 24
- 230000001684 chronic effect Effects 0.000 title claims abstract description 17
- 235000014347 soups Nutrition 0.000 title claims abstract description 10
- 235000002566 Capsicum Nutrition 0.000 title claims description 7
- 239000006002 Pepper Substances 0.000 title claims description 7
- 235000016761 Piper aduncum Nutrition 0.000 title claims description 7
- 235000017804 Piper guineense Nutrition 0.000 title claims description 7
- 235000008184 Piper nigrum Nutrition 0.000 title claims description 7
- 235000009815 Momordica Nutrition 0.000 title claims description 6
- 241000218984 Momordica Species 0.000 title claims description 6
- 244000203593 Piper nigrum Species 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 title description 4
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 7
- 241000205585 Aquilegia canadensis Species 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 3
- 235000009932 Zanthoxylum simulans Nutrition 0.000 abstract 3
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 244000077995 Coix lacryma jobi Species 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 244000248825 Peltandra virginica Species 0.000 abstract 2
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 2
- 241000972672 Phellodendron Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 241000219784 Sophora Species 0.000 abstract 2
- 241000245665 Taraxacum Species 0.000 abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 2
- 235000011477 liquorice Nutrition 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- 230000036407 pain Effects 0.000 description 16
- 230000002401 inhibitory effect Effects 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000722363 Piper Species 0.000 description 5
- 241000588769 Proteus <enterobacteria> Species 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002893 slag Substances 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 241000607626 Vibrio cholerae Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000003958 fumigation Methods 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- IZWBODJDDBCDFA-DXEZAUPJSA-N virgatic acid Chemical compound CC([C@@H]1CC[C@@]23C)(C)[C@@H](O)CC(=O)[C@]1(C)[C@H]3CC=C1[C@@]2(C)CC[C@@]2(C(O)=O)CCC(C)(C)C[C@H]21 IZWBODJDDBCDFA-DXEZAUPJSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000244188 Ascaris suum Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- IZWBODJDDBCDFA-UHFFFAOYSA-N Momordinsaeure Natural products CC12CCC3C(C)(C)C(O)CC(=O)C3(C)C2CC=C2C1(C)CCC1(C(O)=O)CCC(C)(C)CC12 IZWBODJDDBCDFA-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 1
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001572 anti-trichomonad Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229940109990 ruscogenin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- MOCOXAJEZKHXSF-IHMBCTQLSA-M sodium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MOCOXAJEZKHXSF-IHMBCTQLSA-M 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002691 topical anesthesia Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000009271 trench method Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 206010051250 ureteritis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000005925 vesicular stomatitis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种药物配方领域,具体地说是一种用于治疗急慢性盆腔炎的木鳖子花椒汤,采用木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒为原料制备而成,将药物配齐后,加冷水漫过药面,经浸泡、煎煮、过滤制备成汤剂,其特征是原料组成以重量百分比计为:木鳖子4~7、黄柏4~7、苦参6~9、茯苓13~17、蒲公英13~17、金银花8~12、白芷1~4、赤芍5~9、甘草4~7、延胡索6~9、薏苡仁13~17、花椒4~6。本发明原料成本低,治疗急慢性盆腔炎疗效高,无毒副作用,并能增强患者的机体抵抗力。
Description
技术领域
本发明涉及一种中成药制剂,具体地说是一种用于治疗妇女急慢性盆腔炎的复方木鳖子花椒汤。
背景技术
众所周知,盆腔炎是指盆腔生殖器官(子宫体、输卵管、卵巢)及盆腔腹膜与子宫周围的结缔组织炎症,临床出现发热、腹痛、白带增多等症状,称为盆腔炎。盆腔炎分属于中医“癓瘕”、“带下”等范畴。慢性盆腔炎常为急性盆腔炎未能彻底治疗,或患者体质较差病程迁延所致,但亦可无急性盆腔炎病史,如沙眼衣原体所致输尿管炎。慢性盆腔炎病情较顽固,当机体抵抗力较差时,可有急性发作。急性盆腔炎表现为寒战、发热、腹痛拒按、黄带增多似脓、臭秽、腰背酸痛,伴腹膜炎时可有恶心呕吐、腹痛腹泻、炎性肿块形成时有局部压迫刺激症状,或有尿频、尿痛、排便困难,里急后重等。慢性盆腔炎表现为低热起伏,小腹隐痛或腹痛拒按,带下增多,色黄粘稠或有秽气,尿赤便秘。慢性盆腔炎由于病程长,临床主要长期或反复多种抗生素的联合治疗有时并无显著疗效,治疗费用高,患者思想压力大,成为临床的难点,严重影响了盆腔炎患者的身心健康。
发明内容
本发明所要解决的技术问题是为了克服上述现有的技术不足,提供一种成本低,治疗急慢性盆腔炎疗效高,无毒副作用,并能增强患者的机体抵抗力,适用于急慢性盆腔炎。
本发明解决上述技术问题采用的技术方案是:一种用于治疗急慢性盆腔炎的木鳖子花椒汤,采用木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒为原料制备而成,将药物配齐后,加冷水漫过药面,经浸泡、煎煮、过滤制备成汤剂,其特征是原料组成以重量百分比计为:木鳖子4~7、黄柏4~7、苦参6~9、茯苓13~17、蒲公英13~17、金银~花8~12、白芷1~4、赤芍5~9、甘草4~7、延胡索6~9、薏苡仁13~17、花椒4~6。
本发明的有益效果是,原料成本低,治疗急慢性盆腔炎疗效高,无毒副作用,并能增强患者的机体抵抗力。
具体实施方式
下面结合实施例对本发明作进一步的描述:
实施例1:
采用木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒为原料制备而成。其组分(重量%)为木鳖子4.98、黄柏4.5、苦参7.49、茯苓14.9、蒲公英14.9、金银花9.95、白芷2.99、赤芍7.49、甘草5.97、延胡索7.46、薏苡仁14.9、花椒4.47,取上述12种原料总重量为402g,在室温条件下将上述12种中草药加水至3500ml,浸泡5~8小时,然后煎熬60分钟以上,去渣得滤液1500ml,再加水1500ml煎熬60分钟,去渣得滤液500ml,共得药液2000ml。首先让患者排空大小便,取1600ml药液,趁热熏洗会阴部20分钟左右,待药液温度降至40℃左右时开始坐浴,每日一次,每次30分钟左右。坐浴后取上液剩余的400ml,分早晚两次灌肠,每次200ml左右,将患者臀部抬高10厘米,取右侧卧位,取药液200毫升,温度39~41℃,用灭菌的(或一次性)14号导尿管插入肛门内15厘米,液面距肛门低于30厘米,保持每分钟60滴左右,使药液保留2小时左右,每日早晚两次,10天为一疗程,可连续应用2--3个疗程。本发明组中主药木鳖子为葫芦科植物木鳖子的成熟种子,性味苦、微甘、温、有毒。入肝、脾、胃经。具有消中散结、祛毒的功能,可治疗痫肿、疔疮、无名肿毒、癣疮、风湿痹痛、筋脉拘挛等症。化学成分含甾醇、齐墩果酸、木鳖子酸。由柿根皂甙元所成的皂甙、α--酮酸、海藻糖等。可治经络受风寒邪气、筋脉牵连、皮肤疼痛、结聚成核、拘挛麻痹。治打扑损伤、瘀血不散疼痛。黄柏性味苦、寒,入肾、膀胱经。具有清热、燥湿、泻火、解毒的功能。可治疗热痢、泄泻、痔疮、便血、目赤肿痛、口舌生疮、疮疡肿毒等。水煎剂或醇浸剂在体外对金黄色葡萄球菌、白色葡萄球菌、溶血性链球菌、肺炎双球菌、大肠杆菌、绿脓杆菌等有不同程度的抑制作用,许多实验报告证明黄柏对福氏、宋内氏、志贺氏及施氏痢疾杆菌有较强的抑制作用,对结核杆菌也有抑制作用,且对链霉素、对氨水杨酸、异烟肼的结核菌菌株也有效,还有较强的杀钩端螺旋体作用。苦参性味苦、寒、归肝、肾、大肠、小肠经。具有清热、燥湿、杀虫、抗癌的功能,可治疗热毒血痢、便血、黄疸尿闭、赤白带下、阴肿阴痛、湿疹、湿疮、皮肤瘙痒、急性肠炎、菌痢、阿米巴痢疾,外治滴虫性阴道炎等。氧化苦参碱肌注与氧化可的松相似,能明显对抗巴豆油、角叉菜胶(大鼠)和冰醋酸(小鼠)诱发的渗出性炎症,试管内实验证明是直接抑制炎症反应。苦参碱在体内有抗羔羊B型魏氏梭菌及抗羊大肠杆菌作用,各实验组与对照组差异均非常显著。体外试验证明,1%苦参碱对痢疾杆菌、大肠杆菌、变形杆菌、乙型链球菌及金黄色葡萄球菌均有明显的抑制作用,醇浸膏在体外有抗滴虫作用。茯苓为多孔菌科真菌茯苓的干燥菌核,性味甘、平、淡,归心、肺、脾、肾经。具有渗湿利水、益脾和胃、宁心安神等功能,可治疗小便不利、水肿胀满、痰饮咳逆、便溏泻泄、心神不安、淋浊、脾虚、停饮不食、脘闷、三阴疟痰、发热不俞等。抗菌作用,100%的煎剂用平板打洞法,对金黄色葡萄球菌、大肠杆菌和变形杆菌、结核杆菌等有抑制作用。溶血空斑试验表明对小鼠体液免疫有促进作用。蒲公英为菊科植物蒲公英、碱地蒲公英、或同属数种植物的干燥全草。性味苦、甘、寒、归肝、胃经。具有清热解毒、消痈散结的功能。治急性乳腺炎、淋巴腺炎、疔毒疮肿、急性结膜炎、感冒发热、目赤、咽痛、肺痈、肠痈、湿热黄疸、热淋涩痛等。本品为广谱抗菌。50%的鲜草汁用平板挖沟法,对金黄色葡萄球菌、伤寒杆菌、绿脓杆菌有抑制作用,对溶血性链球菌、脑膜炎双球菌、白喉杆菌、变形杆菌、痢疾杆菌等有抑制作用。体外抑菌试验证明,TMP对蒲公英具有抑菌增效作用,复方蒲公英抑菌活性增强。超微结构观察蒲公英对金黄色葡萄球菌的结构改变,蒲公英可使细胞膨大,细胞壁增厚,胞核核糖体均聚集成块,因此干扰了RNA和DNA的合成,阻断细菌生长。金银花为忍冬根植物忍冬,红腺忍冬、山银花或毛花柱忍冬的干燥花蕾或带初开的花。性味甘、寒、归肺、心、胃经。具有清热解毒,凉散风热,用于痈肿疔疮、喉瘅、丹毒、热毒血痢、风热感冒、温病发热等。体外试验证明,金银花对多种致病菌如金黄色葡萄球菌、溶血性链球菌、大肠杆菌、痢疾杆菌、霍乱弧菌、伤寒杆菌、副伤寒杆菌等均有一定的抑制作用,对肺炎球菌、绿脓杆菌、结核杆菌亦有效。金银花对致龋齿、变形链球菌,具有良好的抑菌和杀菌作用。金银花煎剂稀释至1∶1280浓度,仍能促进白细胞的吞噬功能。白芷为伞形科植物白芷或抗白芷的干燥根,性味辛、温、归胃、大肠、肺经。具有散风除湿、通窍止痛、消肿排脓、透疹、解毒的功能。并治头痛、眉棱骨痛,齿痛、鼻渊、寒湿腹痛、肠风痔漏、赤白带下、痈疽疮疡、皮肤燥痒、疥癣、风寒感冒、痔漏便血、白带、痈疮肿毒等。抗菌作用,体外试验,白芷水煎剂对大肠杆菌、痢疾杆菌、伤寒、副伤寒杆菌、绿脓杆菌、变形杆菌及霍乱弧菌等有一定的抑制作用,水浸剂对奥杜氏小芽胞癣菌等致病真菌也有一定的抑制作用。赤芍为毛茛科植物芍药的干燥根,性味苦、微寒,归肝经。具有清热凉血、散瘀止痛的功能,用于温毒发斑,吐血衄血、目赤肿痛、肝郁胁痛、经闭痛经、癓瘕腹痛、跌扑损伤、痈肿疮疡等。抗炎和对免疫系统的作用,赤芍正丁醇提取物3g/kg皮下注射5次,小鼠网状内皮系统吞噬指数显著提高,肝脏重量明显增加,对鸡红细胞激发的迟发型超敏反应亦有显著抑制作用,对活性T淋巴细胞有抑制作用。芍药甙有较弱的抗炎作用。赤芍和芍药甙能抑制大鼠和豚鼠肠管和胃运动,对抗乙酰胆碱引起的平滑肌痉挛,对大鼠子宫平滑肌有抑制作用,并能对抗垂体后叶素引起的子宫收缩,对抗毛果芸香碱引起的大鼠胃紧张。甘草为豆科植物甘草胀果甘草或光果甘草的干燥根及根茎,性味甘、平,归心、肺、脾、胃经,具有补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药的功能,用于中气不足、气虚血衰的各种肿痛,炙用治脾胃虚弱、食少腹痛便溏,、劳倦发热、肺痿咳嗽、心悸、惊痫,生用治咽喉肿痛、消化性溃疡、痈疽疮疡、解药毒及食物中毒。抗病毒及抗菌作用,甘草多糖具有明显的抗水泡性口炎病毒、腺病毒等,能显著抑制细胞病变的发生,使组织培养的细胞得到保护,并有促进角膜混浊等现象提前恢复的作用。抗菌作用,甘草醇提取物及甘草酸钠在体外对金黄色葡萄球菌、结核杆菌、大肠杆菌、阿米巴原虫及滴虫均有抑制作用,对慢性肉芽组织增生的炎症也有明显的抑制作用。对免疫功能的影响,能抑制组织胺释放剂----化合物48/80引起的肥大细胞脱颗粒,从而阻止了过敏介质的释放,避免过敏性休克的发生,并具有肾上腺皮质激素样作用。解痉作用,10%甘草浸膏4mg/kg给兔灌胃后胃运动逐渐减弱,30分钟后胃运动几乎停止,并有保肝作用,可使肝脏的变性和坏死显著减弱。延胡索为罂粟科紫堇属植物延胡索、东北延胡索及齿瓣延胡索的块茎。性味辛、苦、湿,归肝脾经。具有活血、利气、止痛的功能,用于胸胁、皖腹疼痛、经闭痛经、产后瘀阻、跌打肿痛等。具有镇痛、麻醉、催眠、镇静与安定作用。薏苡仁为禾本科植物薏苡仁的干燥成熟种仁,性味甘、淡、凉,归脾、胃、肺经。具有健肝渗湿、除脾止泻、清热排脓的功能,用于水肿、脚气、小便不利、湿脾拘挛、脾虚泄泻、肺痈、肠痈、妇女白带过多、风湿性关节炎等。对中枢神经系统具有镇静、抑制多突触反射、降温与解热、镇痛等作用。体外试验表明,薏苡全草(鲜品)榨汁或根部(干品)煎剂对金黄色葡萄球菌、乙型溶血性链球菌、炭疽杆菌、白喉杆菌有一定的抗菌作用,薏苡仁乙醇提取物也为一种有效抗菌剂。花椒为芸香科植物花椒及青椒的果皮或种子,性味辛、温,归脾、胃、肾经。具有温中止痛、杀虫止痒的功能,用于治疗胃腹冷痛、呕吐、泄泻、血吸虫病、蛔虫病、丝虫病,外用治牙痛、脂溢性皮炎、并可作表面麻醉用。镇痛作用,花椒水提取物5-10g/kg和醚提取物3-6ml/kg对乙醚引起的的小鼠扭体反应有明显的抑制作用。抗菌作用,100%花椒煎剂用平板小杯法,对甲、乙型链球菌、葡萄球菌、肺炎双球菌、炭疽杆菌、白喉杆菌、霍乱弧菌、变形杆菌、伤寒、副伤寒杆菌、大肠杆菌、宋氏痢疾杆菌、绿脓杆菌、革兰氏阴性杆菌等均有抑制作用。挥发油在保温的任氏液中能使猪蛔虫严重中毒,此可能是与所含水芹烯、宁烯、香茅醇等的协同作用的结果。诸药合用,共奏急慢性盆腔炎之特效。
实施例2:
采用木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒为原料制备而成。其组分(重量%)每付为木鳖子5.63、黄柏4.21、苦参7.3、茯苓14.6、蒲公英15.2、金银花9.73、白芷3.21、赤芍7.19、甘草6.27、延胡索8.09、薏苡仁13.9、花椒4.67,取上述12种原料总重量为402g,在室温条件下将上述12种中草药加水至3500ml,浸泡5---8小时,然后煎熬60分钟以上,去渣得滤液1500ml,再加水1500ml煎熬60分钟,去渣得滤液500ml,共得药液2000ml。首先让患者排空大小便,取1600ml药液,趁热熏洗会阴部20分钟左右,待药液温度降至40℃左右时开始坐浴,每日一次,每次30分钟左右。坐浴后取上液剩余的400ml,分早晚两次灌肠,每次200ml左右。将患者臀部抬高10厘米,取右侧卧位,取药液200毫升,温度39~41℃,用灭菌的(或一次性)14号导尿管插入肛门内15cm,液面距肛门低于30cm,保持每分钟60滴左右,使药液保留2小时左右,每日早晚两次,10天为一疗程,可连续应用2--3个疗程。
本发明该种复方木鳖子花椒汤因病人而异,只调整木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒12味中草药的加入量,其加工方法与实施例1或实施例2基本相同,各原料还可按下表所列比例(重量百分比)混合的实施例来实现。
下面结合我院,即山东省威海市文登中心医院进行的临床预试验对本发明作进一步、详细地描述:
1、病例选择:本组60例,女。年龄21-30岁,10例,年龄31-40岁,30例,年龄41-50岁,20例;其中患慢性盆腔炎病的43例,患急性盆腔炎病17例。
2、治疗方法:首先让患者排空大小便,取1600ml药液,趁热熏洗会阴部20分钟左右,待药液温度降至40℃左右时开始坐浴,每日一次,每次30分钟左右。坐浴后取上液剩余的400ml,分早晚两次灌肠,每次200ml左右,将患者臀部抬高10厘米,取右侧卧位,取药液200毫升,温度39~41℃,用灭菌的(或一次性)14号导尿管插入肛门内15厘米,液面距肛门低于30厘米,保持每分钟60滴左右,使药液保留2小时左右,每日早晚两次,10天为一疗程,连续应用3个疗程。
3、治疗效果:使用本发明共治疗60例,结果显效18例,有效40例,无效2例,结果显效率30为%,有效率为67%,无效率为3%,总有效率为97%。
Claims (1)
1.一种用于治疗急慢性盆腔炎的木鳖子花椒汤,采用木鳖子、黄柏、苦参、茯苓、蒲公英、金银花、白芷、赤芍、甘草、延胡索、薏苡仁、花椒为原料制备而成,将药物配齐后,加冷水漫过药面,经浸泡、煎煮、过滤制备成汤剂,其特征是:原料组成以重量百分比计为,木鳖子4~7、黄柏4~7、苦参6~9、茯苓13~17、蒲公英13~17、金银花8~12、白芷1~4、赤芍5~9、甘草4~7、延胡索6~9、薏苡仁13~17、花椒4~6。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101584438A CN101391065B (zh) | 2008-11-03 | 2008-11-03 | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101584438A CN101391065B (zh) | 2008-11-03 | 2008-11-03 | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101391065A CN101391065A (zh) | 2009-03-25 |
CN101391065B true CN101391065B (zh) | 2011-04-13 |
Family
ID=40491706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101584438A Expired - Fee Related CN101391065B (zh) | 2008-11-03 | 2008-11-03 | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101391065B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102641426B (zh) * | 2012-02-17 | 2013-07-31 | 王传梅 | 一种治疗盆腔炎性包块的中药灌肠剂 |
CN109420114A (zh) * | 2017-08-25 | 2019-03-05 | 王停 | 一种用于耐药性慢性盆腔炎调理的中药方剂 |
CN110859940A (zh) * | 2019-12-06 | 2020-03-06 | 大理白族自治州中医医院 | 一种消癥化瘀灌肠液及其制备方法 |
CN114177226A (zh) * | 2021-12-10 | 2022-03-15 | 湖州市妇幼保健院 | 盆腔淤血综合症治疗用中成药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569178A (zh) * | 2004-04-28 | 2005-01-26 | 陈志成 | 一种治疗妇科炎症的中药口服制剂及其制备方法 |
CN101045152A (zh) * | 2006-03-30 | 2007-10-03 | 上海玉森新药开发有限公司 | 一种治疗慢性盆腔炎伴炎性包块的中药组合物 |
-
2008
- 2008-11-03 CN CN2008101584438A patent/CN101391065B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569178A (zh) * | 2004-04-28 | 2005-01-26 | 陈志成 | 一种治疗妇科炎症的中药口服制剂及其制备方法 |
CN101045152A (zh) * | 2006-03-30 | 2007-10-03 | 上海玉森新药开发有限公司 | 一种治疗慢性盆腔炎伴炎性包块的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101391065A (zh) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102697961B (zh) | 一种治疗阴道炎的妇科清洗液及其制作方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN101869626B (zh) | 中药复方制剂舒阴液及其制备与应用 | |
CN101537107A (zh) | 有效治疗皮肤真菌病的外用擦剂及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN103007124A (zh) | 一种治疗妇科炎症的中药制剂 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
CN104383053B (zh) | 一种治疗尿路感染的中药制剂及制备方法 | |
CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
CN101129672A (zh) | 一种内服治疗细菌性痢疾的中药组合物 | |
CN101732614B (zh) | 一种治疗泌尿系感染的中药 | |
CN101856481A (zh) | 一种消肿散结的外用膏剂 | |
CN103751532A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN108853277A (zh) | 一种用于针灸的中药消毒液 | |
CN102940831A (zh) | 一种用于抑菌与治疗妇科炎症的外用泡腾片 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN102716357B (zh) | 一种不留疤痕的烫伤药及其制备方法 | |
CN105477490A (zh) | 一种用于治疗妇科外阴瘙痒的药物制剂及用途 | |
CN102895610A (zh) | 一种治疗水肿的药物 | |
CN104587202A (zh) | 一种治疗湿疹的中药膏剂及其制备方法 | |
CN103933417A (zh) | 一种用于治疗皮肤病的中药制剂 | |
CN1283282C (zh) | 一种治疗阑尾炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110413 Termination date: 20111103 |